8-K Announcements
6Material company update
Jun 1, 2026·SEC
Material company update
Apr 10, 2026·SEC
Material company update
Apr 2, 2026·SEC
Exicure, Inc.(XCUR)Earnings, Financials & Key Ratios
XCUR•NASDAQ
Price updated Jun 19, 2026
AboutExicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease and Angelman syndrome. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.Show more
- Revenue$0-100.0%
- EBITDA-$10M+15.3%
- Net Income-$5M+49.0%
- EPS (Diluted)-0.79+50.3%
- ROE-92.47%+53.3%
XCUR Key Insights
Exicure, Inc. (XCUR) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y profit CAGR of 27.5%
- ✓High quality earnings: Operating CF exceeds net income
- ✓Healthy 5Y average net margin of 3774.2%
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Weak momentum: RS Rating 6 (bottom 6%)
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when XCUR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
XCUR Price & Volume
Exicure, Inc. (XCUR) stock price & volume — 10-year historical chart
Loading chart...
XCUR Growth Metrics
Exicure, Inc. (XCUR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-66.91%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-67.5%
Return on Capital
10 Years-76.19%
5 Years-83.71%
3 Years-101.7%
Last Year-91.4%
XCUR Recent Earnings
Exicure, Inc. (XCUR) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 3/12 qtrs (100%)●Beat Revenue 1/12 qtrs (100%)
Q2 2026Latest
May 29, 2026Metric
Actual
Est
EPS
$0.29+98.4%
$18.60
Rev
—
$2M
Q2 2026
Mar 25, 2026Metric
Actual
Est
EPS
$0.46+51.6%
$0.95
Rev
—
$4M
Q4 2025
Nov 7, 2025Metric
Actual
Est
EPS
$0.39
—
Rev
—
—
Q3 2025
Aug 8, 2025Metric
Actual
Est
EPS
$0.41
—
Rev
—
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 29, 2026 | $0.29vs $18.60+98.4% | —vs $2M |
| Q2 2026 | Mar 25, 2026 | $0.46vs $0.95+51.6% | —vs $4M |
| Q4 2025 | Nov 7, 2025 | $0.39 | — |
| Q3 2025 | Aug 8, 2025 | $0.41 | — |
Based on last 12 quarters of dataView full earnings history →
XCUR Peer Comparison
Exicure, Inc. (XCUR) competitors in RNA and Genome Editing Developers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SRPT | 1.85B | 17.53 | -2.46 | 15.58% | 2.98% | 4.89% | 0.91 | |
 ARWR | 11.52B | 81.82 | -6706.56 | 232.58% | -48.38% | -55.09% | 0.73 | |
 NTLA | 1.76B | 15.67 | -4.11 | 16.92% | -5.97% | -57.27% | 0.14 | |
 BEAM | 3.51B | 34.14 | -42.15 | 120.01% | -49.17% | -5.89% | 0.24 | |
 EDIT | 263.37M | 2.69 | -1.49 | 25.39% | -281.59% | -6.77% | 2.81 | |
 CRSP | 5.22B | 54.09 | -8.36 | -89.97% | -138.57% | -30.88% | 0.21 | |
 IONS | 12.25B | 74.12 | -31.14 | 33.87% | -30.87% | -58.57% | 5.35 | |
 REGN | 63.37B | 609.94 | 14.70 | 0.99% | 29.65% | 14.32% | 0.09 |
Compare XCUR vs Peers
Exicure, Inc. (XCUR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
XCUR Income Statement
Exicure, Inc. (XCUR) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 9.72M | 118K | 1.3M | 16.61M | -483K | 28.83M | 0 | 500K | 0 | 0 |
Revenue Growth % | 838.13% | -98.79% | 998.31% | 1181.87% | -102.91% | 6068.12% | -100% | - | -100% | - |
Cost of Goods Sold | 13.08M | 14.12M | 0 | 32.09M | 0 | 1.86M | 1.42M | 0 | 460K | 263K |
COGS % of Revenue | 134.58% | 11965.25% | - | 193.19% | - | 6.44% | - | - | - | - |
Gross Profit | -3.36M▲ 0% | -14M▼ 316.6% | 1.3M▲ 109.3% | -15.48M▼ 1294.5% | -483K▲ 96.9% | 26.97M▲ 5683.9% | -1.42M▼ 105.3% | 500K▲ 135.1% | -460K▼ 192.0% | -263K▲ 0% |
Gross Margin % | -34.58% | -11865.25% | 100% | -93.19% | 100% | 93.56% | - | 100% | - | - |
Gross Profit Growth % | 73.37% | -316.57% | 109.26% | -1294.52% | 96.88% | 5683.85% | -105.28% | 135.14% | -192% | - |
Operating Expenses | 20.13M | 21.94M | 27.91M | 9.96M | 62.07M | 28.8M | 13.57M | 12.73M | 9.66M | 8.5M |
OpEx % of Revenue | 207.08% | 18590.68% | 2153.78% | 59.92% | -12850.1% | 99.91% | - | 2546.4% | - | - |
Selling, General & Admin | 7.05M | 7.82M | 8.57M | 9.96M | 13.09M | 10.89M | 12.65M | 5.45M | 6.83M | 5.8M |
SG&A % of Revenue | 72.5% | 6625.42% | 661.5% | 59.92% | -2709.52% | 37.78% | - | 1089.8% | - | - |
Research & Development | 13.08M | 14.12M | 19.34M | 32.09M | 48.98M | 19.77M | 1.42M | 0 | 3.29M | 2.79M |
R&D % of Revenue | 134.58% | 11965.25% | 1492.28% | 193.19% | -10140.58% | 68.57% | - | - | - | - |
Other Operating Expenses | 191K | -249K | 0 | -32.09M | 0 | -1.86M | -503K | 7.28M | -460K | -93K |
Operating Income | -10.41M▲ 0% | -21.82M▼ 109.7% | -26.62M▼ 22.0% | -25.44M▲ 4.4% | -62.55M▼ 145.9% | -1.83M▲ 97.1% | -15M▼ 719.0% | -12.23M▲ 18.4% | -10.12M▲ 17.3% | -8.76M▲ 0% |
Operating Margin % | -107.08% | -18490.68% | -2053.78% | -153.11% | 12950.1% | -6.35% | - | -2446.4% | - | - |
Operating Income Growth % | 35.61% | -109.66% | -21.99% | 4.44% | -145.91% | 97.07% | -719.01% | 18.43% | 17.29% | - |
EBITDA | -10.18M | -21.46M | -25.89M | -23.99M | -60.77M | 25K | -13.62M | -11.41M | -9.66M | -8.3M |
EBITDA Margin % | -104.69% | -18187.29% | -1997.92% | -144.4% | 12581.78% | 0.09% | - | -2281.6% | - | - |
EBITDA Growth % | 36.33% | -110.92% | -20.65% | 7.35% | -153.32% | 100.04% | -54584% | 16.25% | 15.35% | -7.53% |
D&A (Non-Cash Add-back) | 232K | 358K | 724K | 1.45M | 1.78M | 1.86M | 1.38M | 824K | 460K | 462K |
EBIT | -10.22M | -21.74M | -25.52M | -24.09M | -62.41M | -1.78M | -16.91M | -9.68M | -10.12M | -8.74M |
Net Interest Income | -795K | -668K | -608K | 399K | -1.55M | -580K | 32K | -10K | 28K | 23K |
Interest Income | 0 | 4K | 178K | 972K | 141K | 15K | 32K | 8K | 29K | 24K |
Interest Expense | 795K | 672K | 786K | 573K | 1.69M | 595K | 0 | 18K | 1K | 1K |
Other Income/Expense | -604K | -594K | 314K | 768K | -1.55M | -542K | -1.92M | 2.54M | 4.54M | -1.66M |
Pretax Income | -11.01M▲ 0% | -22.41M▼ 103.6% | -26.3M▼ 17.4% | -24.67M▲ 6.2% | -64.1M▼ 159.9% | -2.37M▲ 96.3% | -16.91M▼ 612.8% | -9.69M▲ 42.7% | -5.58M▲ 42.4% | -10.42M▲ 0% |
Pretax Margin % | -113.29% | -18994.07% | -2029.55% | -148.49% | 13271.64% | -8.23% | - | -1938.6% | - | - |
Income Tax | 0 | 0 | 0 | 0 | 0 | 209K | 0 | 8K | -634K | -634K |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | -8.81% | 0% | -0.08% | 11.36% | 6.09% |
Net Income | -11.01M▲ 0% | -22.41M▼ 103.6% | -26.3M▼ 17.4% | -24.67M▲ 6.2% | -64.1M▼ 159.9% | -2.58M▲ 96.0% | -16.91M▼ 555.1% | -9.7M▲ 42.6% | -4.95M▲ 49.0% | -9.78M▲ 0% |
Net Margin % | -113.29% | -18994.07% | -2029.55% | -148.49% | 13271.64% | -8.96% | - | -1940.2% | - | - |
Net Income Growth % | 35% | -103.55% | -17.36% | 6.22% | -159.86% | 95.97% | -555.07% | 42.65% | 49.02% | -66.91% |
Net Income (Continuing) | -11.01M | -22.41M | -26.3M | -24.67M | -64.1M | -2.58M | -16.91M | -9.7M | -4.95M | -9.78M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -8.37▲ 0% | -16.32▼ 95.0% | -13.68▲ 16.2% | -8.49▲ 37.9% | -21.70▼ 155.6% | -0.56▲ 97.4% | -2.11▼ 276.8% | -1.59▲ 24.6% | -0.79▲ 50.3% | -1.54▲ 0% |
EPS Growth % | 35.02% | -94.98% | 16.18% | 37.94% | -155.59% | 97.42% | -276.79% | 24.64% | 50.31% | -67.5% |
EPS (Basic) | -8.37 | -16.32 | -13.68 | -8.49 | -21.70 | -0.56 | -2.11 | -1.59 | -0.79 | - |
Diluted Shares Outstanding | 1.32M | 1.37M | 1.92M | 2.91M | 2.95M | 4.62M | 8.01M | 6.1M | 6.3M | 6.37M |
Basic Shares Outstanding | 1.32M | 1.37M | 1.92M | 2.91M | 2.95M | 4.62M | 8.01M | 6.1M | 6.3M | 6.37M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
XCUR Balance Sheet
Exicure, Inc. (XCUR) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 27.64M | 27.66M | 112.78M | 86.32M | 43.67M | 10.05M | 2.02M | 13.67M | 4.62M | 3.53M |
Cash & Short-Term Investments | 25.76M | 26.27M | 110.79M | 82.08M | 39.14M | 8.58M | 816K | 12.51M | 3.75M | 2.6M |
Cash Only | 25.76M | 26.27M | 48.46M | 33.26M | 34.64M | 8.58M | 816K | 12.51M | 3.75M | 2.6M |
Short-Term Investments | 0 | 0 | 62.33M | 48.82M | 4.5M | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 30K | 3K | 35K | 11K | 0 | 0 | 250K | 521K | 58K | 60K |
Days Sales Outstanding | 1.13 | 9.28 | 9.86 | 0.24 | - | - | - | 380.33 | - | - |
Inventory | 0 | 646K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | 16.7 | - | - | - | - | - | - | - | - |
Other Current Assets | 0 | 746K | 0 | 1.2M | 1.28M | 853K | 24K | 69K | 820K | 868K |
Total Non-Current Assets | 1.35M | 1.09M | 2.49M | 14.12M | 21.2M | 13.28M | 9.56M | 1.38M | 9.42M | 9.22M |
Property, Plant & Equipment | 1.32M | 1.06M | 2.46M | 12.73M | 11.88M | 9.79M | 6.57M | 26K | 306K | 219K |
Fixed Asset Turnover | 7.38x | 0.11x | 0.53x | 1.31x | -0.04x | 2.95x | - | 19.23x | - | 0.00x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.4M | 4.4M |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.78M | 3.78M |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 1.2M | 1.2M | 0 | 0 | 0 |
Other Non-Current Assets | 32K | 32K | 32K | 1.39M | 9.32M | 2.29M | 1.78M | 1.36M | 928K | 821K |
Total Assets | 28.99M▲ 0% | 28.76M▼ 0.8% | 115.26M▲ 300.8% | 100.44M▼ 12.9% | 64.87M▼ 35.4% | 23.33M▼ 64.0% | 11.58M▼ 50.4% | 15.06M▲ 30.0% | 14.04M▼ 6.7% | 12.76M▲ 0% |
Asset Turnover | 0.34x | 0.00x | 0.01x | 0.17x | -0.01x | 1.24x | - | 0.03x | - | 0.00x |
Asset Growth % | 40.88% | -0.8% | 300.83% | -12.86% | -35.42% | -64.04% | -50.36% | 30.02% | -6.74% | 73.86% |
Total Current Liabilities | 3.36M | 2.04M | 31.09M | 13.73M | 34.07M | 1.64M | 2.51M | 3.07M | 3.89M | 4.46M |
Accounts Payable | 1.05M | 500K | 1.81M | 1.87M | 3.41M | 361K | 1.63M | 1.03M | 1.69M | 2.44M |
Days Payables Outstanding | 29.27 | 12.93 | - | 21.22 | - | 70.99 | 418.35 | - | 1.34K | 2.53K |
Short-Term Debt | 0 | 0 | 4.96M | 0 | 6.87M | 539K | 0 | 0 | 176K | 22K |
Deferred Revenue (Current) | 1.03M | 0 | 21.87M | 0 | 17.32M | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 1.22M | 8.34M | 0 | 707K | 0 | 0 | 2.02M | 1.99M |
Current Ratio | 8.24x | 13.54x | 3.63x | 6.29x | 1.28x | 6.13x | 0.81x | 4.45x | 1.19x | 0.79x |
Quick Ratio | 8.24x | 13.22x | 3.63x | 6.29x | 1.28x | 6.13x | 0.81x | 4.45x | 1.19x | 0.79x |
Cash Conversion Cycle | - | 13.05 | - | - | - | - | - | - | - | - |
Total Non-Current Liabilities | 5.66M | 5.76M | 3.43M | 25.2M | 19.57M | 6.77M | 6.04M | 5.21M | 6.23M | 6.2M |
Long-Term Debt | 4.86M | 4.92M | 0 | 16.59M | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 59K | 7.96M | 7.4M | 6.77M | 6.04M | 5.21M | 0 | 26K |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 423K | 846K |
Other Non-Current Liabilities | 801K | 836K | 414K | 656K | 656K | 0 | 0 | 0 | 5.8M | 5.77M |
Total Liabilities | 9.01M | 7.8M | 34.52M | 38.94M | 53.64M | 8.41M | 8.55M | 8.28M | 10.12M | 10.66M |
Total Debt | 4.86M | 4.92M | 5.32M | 24.77M | 14.74M | 7.31M | 6.67M | 5.93M | 176K | 22K |
Net Debt | -20.91M | -21.34M | -43.14M | -8.49M | -19.91M | -1.27M | 5.85M | -6.57M | -3.57M | -2.58M |
Debt / Equity | 0.24x | 0.24x | 0.07x | 0.40x | 1.31x | 0.49x | 2.20x | 0.88x | 0.04x | 0.01x |
Debt / EBITDA | - | - | - | - | - | 292.24x | - | - | - | -0.00x |
Net Debt / EBITDA | - | - | - | - | - | -50.84x | - | - | - | 0.31x |
Interest Coverage | -12.85x | -32.35x | -32.46x | -42.05x | -36.91x | -2.99x | - | -537.50x | -10117.00x | -8745.00x |
Total Equity | 19.98M▲ 0% | 20.95M▲ 4.9% | 80.75M▲ 285.4% | 61.51M▼ 23.8% | 11.23M▼ 81.7% | 14.92M▲ 32.9% | 3.03M▼ 79.7% | 6.77M▲ 123.4% | 3.93M▼ 42.0% | 2.1M▲ 0% |
Equity Growth % | 715.97% | 4.89% | 285.39% | -23.83% | -81.74% | 32.85% | -79.69% | 123.42% | -42.03% | 674.23% |
Book Value per Share | 15.19 | 15.26 | 42.00 | 21.16 | 3.80 | 3.23 | 0.38 | 1.11 | 0.62 | 0.33 |
Total Shareholders' Equity | 19.98M | 20.95M | 80.75M | 61.51M | 11.23M | 14.92M | 3.03M | 6.77M | 3.93M | 2.1M |
Common Stock | 4K | 4K | 9K | 9K | 11K | 0 | 0 | 1K | 1K | 1K |
Retained Earnings | -33.62M | -54.99M | -81.3M | -105.97M | -170.07M | -172.65M | -189.56M | -199.26M | -204.21M | -206.04M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | -27K | 83K | -2K | 0 | 0 | 0 | -2K | -2K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XCUR Cash Flow Statement
Exicure, Inc. (XCUR) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -19.79M | -19.49M | 1.32M | -39.27M | -34.82M | -35.66M | -10.36M | -2.91M | -8.55M | -8.1M |
Operating CF Margin % | -203.61% | -16514.41% | 101.62% | -236.38% | 7208.9% | -123.7% | - | -582% | - | - |
Operating CF Growth % | -291.86% | 1.53% | 106.76% | -3081.78% | 11.33% | -2.41% | 70.95% | 71.9% | -193.99% | -788.66% |
Net Income | -11.01M | -22.41M | -26.3M | -24.67M | -64.1M | -2.58M | -16.91M | -9.7M | -4.95M | -9.78M |
Depreciation & Amortization | 232K | 358K | 724K | 1.45M | 1.78M | 1.86M | 1.38M | 824K | 460K | 586K |
Stock-Based Compensation | 1.46M | 1.81M | 1.84M | 2.18M | 2.94M | 1.37M | 1.35M | 22K | 2K | 3K |
Deferred Taxes | -214K | 274K | -386K | 0 | 0 | 0 | 0 | 0 | -634K | -634K |
Other Non-Cash Items | -25K | 496K | 228K | 99K | 460K | 514K | 2.92M | 5.31M | -4.58M | 6.81M |
Working Capital Changes | -10.45M | -11K | 25.21M | -18.33M | 24.11M | -36.81M | 914K | 631K | 1.14M | -145K |
Change in Receivables | -13K | 10K | -32K | 24K | 11K | 0 | 0 | -506K | 1.34M | 3K |
Change in Inventory | -2.35M | 775K | -372K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 195K | -557K | 789K | 364K | 1.58M | -3.05M | 1.27M | -193K | 177K | 1.36M |
Cash from Investing | -926K | -94K | -63.43M | 10.14M | 43.09M | 4.7M | -1.08M | 0 | -1.81M | 283K |
Capital Expenditures | -926K | -94K | -1.08M | -3.17M | -968K | -10K | 0 | 0 | -1K | -215K |
CapEx % of Revenue | 9.53% | 79.66% | 83.49% | 19.09% | -200.41% | 0.03% | - | - | - | - |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.81M | 42K |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | 0 | 0 | 0 | 205K | 922K | 0 | 0 | 456K |
Cash from Financing | 26.86M | 20.09M | 84.31M | 15.13M | 1.12M | -3.1M | 3.67M | 13.4M | 1.6M | 0 |
Debt Issued (Net) | -1M | 0 | 0 | 12.5M | -10M | -7.5M | 0 | 1M | 0 | 0 |
Equity Issued (Net) | 31.51M | 22M | 90.75M | 2.97M | 11.48M | 5.04M | 5.44M | 12.4M | 1.6M | 0 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -79K |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -3.66M | -1.92M | -6.44M | -344K | -362K | -645K | -1.77M | 0 | 0 | 79K |
Net Change in Cash | 6.14M▲ 0% | 504K▼ 91.8% | 22.19M▲ 4303.2% | -14M▼ 163.1% | 9.38M▲ 167.0% | -34.07M▼ 463.1% | -7.76M▲ 77.2% | 10.49M▲ 235.2% | -8.76M▼ 183.5% | -7.82M▲ 0% |
Free Cash Flow | -20.71M▲ 0% | -19.58M▲ 5.5% | 235K▲ 101.2% | -42.44M▼ 18160.0% | -35.79M▲ 15.7% | -35.67M▲ 0.3% | -10.36M▲ 71.0% | -2.91M▲ 71.9% | -8.56M▼ 194.0% | -8.1M▲ 0% |
FCF Margin % | -213.14% | -16594.07% | 18.13% | -255.47% | 7409.32% | -123.74% | - | -582% | - | - |
FCF Growth % | -280.51% | 5.47% | 101.2% | -18160% | 15.68% | 0.33% | 70.96% | 71.9% | -194.02% | -99.61% |
FCF per Share | -15.75 | -14.26 | 0.12 | -14.60 | -12.12 | -7.72 | -1.29 | -0.48 | -1.36 | -1.27 |
FCF Conversion (FCF/Net Income) | 1.80x | 0.87x | -0.05x | 1.59x | 0.54x | 13.81x | 0.61x | 0.30x | 1.73x | 0.83x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
XCUR Key Ratios
Exicure, Inc. (XCUR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -98.21% | -109.53% | -51.73% | -34.68% | -176.25% | -19.74% | -188.43% | -197.92% | -92.47% | -179.41% |
Return on Invested Capital (ROIC) | - | - | -107.29% | -42.1% | -211.6% | -55.21% | -99.84% | -202.09% | -2734.32% | -624.45% |
Gross Margin | -34.58% | -11865.25% | 100% | -93.19% | 100% | 93.56% | - | 100% | - | - |
Net Margin | -113.29% | -18994.07% | -2029.55% | -148.49% | 13271.64% | -8.96% | - | -1940.2% | - | - |
Debt / Equity | 0.24x | 0.24x | 0.07x | 0.40x | 1.31x | 0.49x | 2.20x | 0.88x | 0.04x | 0.01x |
Interest Coverage | -12.85x | -32.35x | -32.46x | -42.05x | -36.91x | -2.99x | - | -537.50x | -10117.00x | -8745.00x |
FCF Conversion | 1.80x | 0.87x | -0.05x | 1.59x | 0.54x | 13.81x | 0.61x | 0.30x | 1.73x | 0.83x |
Revenue Growth | 838.13% | -98.79% | 998.31% | 1181.87% | -102.91% | 6068.12% | -100% | - | -100% | - |
Related:XCUR Dividend History·XCUR Revenue History·XCUR Price History·XCUR P/E History·XCUR Financial Ratios·XCUR Institutional Holders
XCUR SEC Filings & Documents
Exicure, Inc. (XCUR) SEC filings — annual & quarterly reports (10-K, 10-Q)
XCUR Frequently Asked Questions
Exicure, Inc. (XCUR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Exicure, Inc. (XCUR) saw revenue decline by 100.0% over the past year.
Exicure, Inc. (XCUR) reported a net loss of $9.8M for fiscal year 2025.
Dividend & Returns
Exicure, Inc. (XCUR) has a return on equity (ROE) of -92.5%. Negative ROE indicates the company is unprofitable.
Exicure, Inc. (XCUR) had negative free cash flow of $8.1M in fiscal year 2025, likely due to heavy capital investments.